Literature DB >> 7839948

Cardiovascular systemic invasion by hepatocellular carcinoma: incidence and pattern in a west African population.

E A Ayoola1, I O Olubuyide, J Thomas.   

Abstract

To determine the frequency of cardiovascular systemic invasion by hepatocellular carcinoma (HCC). Eighty-one Nigerian patients who had autopsy examinations were studied. Of these, 36 (44%) had tumour thrombi within the cardiovascular system (CVS) or metastases to the heart itself. Compared with the patients without CVS invasion, no clinicopathologic findings distinguished these two groups from each other. Furthermore, CVS invasion did not worsen the generally bad prognosis of these patients with liver cancer. It is concluded that CVS invasion is frequent and difficult to diagnose by clinical examination. Patients who are selected to undergo hepatic resection must be assessed by imaging techniques to exclude CVS invasion. However, it is unlikely that frequent and routine imaging procedures will affect the generally bad prognosis of the majority of the patients.

Entities:  

Mesh:

Year:  1994        PMID: 7839948

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  3 in total

Review 1.  Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.

Authors:  Kazuhiko Sakamoto; Hiroaki Nagano
Journal:  Surg Today       Date:  2017-12-26       Impact factor: 2.549

2.  A case of left atrial metastasis from hepatocellular carcinoma: life-saving palliative resection using cardiopulmonary bypass.

Authors:  Jae-Bin Seo; Jun Sung Kim; Dong Seop Jeong; Woo-Young Chung; Sang-Hyun Kim; Myoung-A Kim; Joo-Hee Zo
Journal:  Korean Circ J       Date:  2011-09-29       Impact factor: 3.243

3.  Risk factors for patients with stage IVB hepatocellular carcinoma and extension into the heart: prognostic and therapeutic implications.

Authors:  Chung Hwan Jun; Da Woon Sim; Sang Ho Kim; Hyoung Ju Hong; Min Woo Chung; Sung Bum Cho; Chang Hwan Park; Young Eun Joo; Hyun Soo Kim; Sung Kyu Choi; Jong Sun Rew
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.